key: cord-1006655-k6j0vply
authors: Gao, Yong; Li, Tuantuan; Han, Mingfeng; Li, Xiuyong; Wu, Dong; Xu, Yuanhong; Zhu, Yulin; Liu, Yan; Wang, Xiaowu; Wang, Linding
title: Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
date: 2020-04-10
journal: J Med Virol
DOI: 10.1002/jmv.25770
sha: 5b27b9e946f12a104c00e1f524a93a6efd449a03
doc_id: 1006655
cord_uid: k6j0vply

The role of clinical laboratory data in the differential diagnosis of the severe forms of COVID‐19 has not been definitely established. The aim of this study was to look for the warning index in severe COVID‐19 patients. We investigated 43 adult patients with COVID‐19. The patients were classified into mild group (28 patients) and severe group (15 patients). A comparison of the hematological parameters between the mild and severe groups showed significant differences in interleukin‐6 (IL‐6), d‐dimer (d‐D), glucose, thrombin time, fibrinogen, and C‐reactive protein (P < .05). The optimal threshold and area under the receiver operator characteristic curve (ROC) of IL‐6 were 24.3 and 0.795 µg/L, respectively, while those of d‐D were 0.28 and 0.750 µg/L, respectively. The area under the ROC curve of IL‐6 combined with d‐D was 0.840. The specificity of predicting the severity of COVID‐19 during IL‐6 and d‐D tandem testing was up to 93.3%, while the sensitivity of IL‐6 and d‐D by parallel test in the severe COVID‐19 was 96.4%. IL‐6 and d‐D were closely related to the occurrence of severe COVID‐19 in the adult patients, and their combined detection had the highest specificity and sensitivity for early prediction of the severity of COVID‐19 patients, which has important clinical value.

Since December 8, 2019, several cases of pneumonia of unknown etiology have been reported in Wuhan, a city within the Hubei province of China. The disease and the virus that causes it have been named as COVID-19 and SARS-COV-2, respectively. In January 2020, the outbreak spread to multiple cities in China, with cases now confirmed in multiple countries. [1] [2] [3] Human to human transmission is strongly associated with COVID-9 and SARS-COV-2. Respiratory droplets and human to human contacts are the main routes of transmission of the virus. 4 In the early stages of this disease, symptoms of severe acute respiratory infection occur, with some patients rapidly developing acute respiratory distress syndrome (ARDS) and other serious complications, which are eventually followed by multiple organ failure. 5 Therefore, early diagnosis and timely treatment of critical cases is very crucial. At present, the occurrence, development, mechanism of prognosis and immune status of patients with Xiaowu Wang and Linding Wang contributed equally as the last authors. COVID-19 are still unclear. In this study, we have assessed the hematological characteristics of the patients. Also, we have determined the correlation between clinical laboratory data and the severity of COVID-19 in adult patients. Moreover, we have determined the predictive value of clinical laboratory data for the severity of COVID-19.

We conducted a retrospective study on COVID-9 patients from January 23, 2020 to February 2, 2020 

Data on AST, urea, Cr, Cys-c, UA, CRP, WBC, LYM, MONO, NEU, TT, FIB, APTT, PT levels were expressed as means ± standard deviation (SD). Differences in the levels of these parameters between the mild and severe patients of the disease were determined with the Student t test, as the data were normally distributed. sex was compared using the χ 2 test, and ages were shown as means ± SD. Since the data regarding ALT, GLU, PCT, IL-6, and D-D levels were not normally distributed, they were compared between the two groups using Mann-Whitney U tests.

The results were presented in terms of the median (interquartile range [IQR]). The area under the curve (AUC) and the 95% confidence interval (CI) of the receiver operator characteristic (ROC) curve and logistic regression analysis was computed using the predicted probability of the severe COVID-19. The optimal cutoff points to predict the severity of COVID-19 were determined by Youden's index. A two-sided P value less than .05 was considered significant. The results of the analysis were obtained using SPSS for windows.

The study involved 43 patients. The mean age of the 15 patients Table 1 . The difference between the two groups was significant in diabetes and chronic obstructive pulmonary disease.

The hematological characteristics of the patients are shown in Table 2 

The ROC curve was used to analyze the early-warning efficiency and the optimal prediction threshold of COVID-19 intensification.

The AUC of IL-6 which was used to predict the severity of Figure 1 and Table 3 .

The severe COVID-19 was as the dependent variable (yes = 1, no Table 4 . Abbreviations: CI, confidence interval; D-D, D-dimer; IL-6, interleukin-6; OR, odds ratio. indicates that CoV consumes many immune cells and inhibits the body's cellular immune function. Damage to T lymphocytes might be an important factor leading to exacerbations of patients. 8 

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-23

First case of 2019 novel coronavirus in the United States

Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

SARS and other coronaviruses as causes of pneumonia

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

SARS and MERS: recent insights into emerging coronaviruses

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

The authors declare that there are no conflict of interests.

All authors participated in the research design. YG, XW, and LW performed the data management and statistical analyses after discussion with all authors. All authors participated in data interpretation and in writing the manuscript. All authors took responsibility for the decision to submit for publication.

http://orcid.org/0000-0001-6877-5791